Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Bone Marrow Transplantation
|
May 21, 2024
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience
Marta Castelli, Maria Caterina Micò, Anna Grassi, et al.
Immunobiology
|
September 18, 2020
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, et al.
Frontiers in Immunology
|
June 26, 2023
Potency assays and biomarkers for cell-based advanced therapy medicinal products
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Blood Cancer Journal
|
October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
Simonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group
Francesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Blood Cancer Journal
|
November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07
Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2017
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
Martino Introna, Federico Lussana, Alessandra Algarotti, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Bone Marrow Transplantation
|
May 21, 2024
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience
Marta Castelli, Maria Caterina Micò, Anna Grassi, et al.
Immunobiology
|
September 18, 2020
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, et al.
Frontiers in Immunology
|
June 26, 2023
Potency assays and biomarkers for cell-based advanced therapy medicinal products
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Blood Cancer Journal
|
October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
Simonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group
Francesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Blood Cancer Journal
|
November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07
Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2017
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
Martino Introna, Federico Lussana, Alessandra Algarotti, et al.
Page
of 9